Chung‐Wei Lin

Papers

Total Citations

H-Index

About

Dr. Chung-Wei Lin is a clinician-researcher specializing in otolaryngology and sleep-disordered breathing, with a particular focus on obstructive sleep apnea (OSA) and its systemic cardiovascular implications. His work bridges surgical intervention and metabolic biomarkers, most notably through investigations into serum homocysteine levels—a well-established cardiovascular risk factor—in severe OSA patients. In his landmark 2023 study, Dr. Lin demonstrated that patients undergoing transoral robotic surgery for OSA (TORS-OSA) exhibit elevated homocysteine levels preoperatively, and that these levels can be significantly reduced following successful surgical treatment. This finding provides compelling evidence that TORS-OSA not only alleviates airway obstruction but may also mitigate long-term cardiovascular risk. With 9 citations to date, this work has already influenced clinical perspectives on the broader health benefits of OSA surgery. Dr. Lin’s research is at the forefront of integrating surgical outcomes with metabolic and cardiovascular endpoints, offering a more holistic understanding of OSA management. His contributions are particularly valuable for students and clinicians interested in the intersection of sleep medicine, head and neck surgery, and preventive cardiology.